| ISIN | CH0368190739 |
|---|---|
| Valor Number | 36819073 |
| Bloomberg Global ID | CHSRI SW |
| Fund Name | UBS ETF (CH) - UBS MSCI Switzerland IMI Socially Responsible ETF CHF dis |
| Fund Provider |
UBS Fund Management (Switzerland) AG
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
| Fund Provider | UBS Fund Management (Switzerland) AG |
| Representative in Switzerland | |
| Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
| Asset Class | Asset Allocation |
| EFC Category | Equity Switzerland |
| Distribution Policy | Distribution |
| Home Country | Switzerland |
| Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
| Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
| Investment Strategy *** | n/a |
| Peculiarities |
| Current Price * | 19.35 CHF | 16.01.2026 |
|---|---|---|
| Previous Price * | 19.38 CHF | 15.01.2026 |
| 52 Week High * | 19.38 CHF | 15.01.2026 |
| 52 Week Low * | 15.66 CHF | 09.04.2025 |
| NAV * | 19.35 CHF | 16.01.2026 |
| Issue Price * | 19.35 CHF | 16.01.2026 |
| Redemption Price * | 19.35 CHF | 16.01.2026 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 528,127,236 | |
| Unit/Share Assets *** | 269,639,118 | |
| Trading Information SIX | ||
| YTD Performance | +1.83% |
31.12.2025 - 16.01.2026
31.12.2025 16.01.2026 |
|---|---|---|
| 1 month | +3.38% |
16.12.2025 - 16.01.2026
16.12.2025 16.01.2026 |
| 3 months | +4.57% |
16.10.2025 - 16.01.2026
16.10.2025 16.01.2026 |
| 6 months | +7.00% |
16.07.2025 - 16.01.2026
16.07.2025 16.01.2026 |
| 1 year | +11.44% |
16.01.2025 - 16.01.2026
16.01.2025 16.01.2026 |
| 2 years | +24.04% |
16.01.2024 - 16.01.2026
16.01.2024 16.01.2026 |
| 3 years | +27.72% |
16.01.2023 - 16.01.2026
16.01.2023 16.01.2026 |
| 5 years | +34.48% |
18.01.2021 - 16.01.2026
18.01.2021 16.01.2026 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| UBS Group AG Registered Shares | 11.93% | |
|---|---|---|
| Roche Holding AG | 11.67% | |
| Novartis AG Registered Shares | 10.79% | |
| ABB Ltd | 10.54% | |
| Lonza Group Ltd | 10.05% | |
| Zurich Insurance Group AG | 9.88% | |
| Alcon Inc | 9.70% | |
| Nestle SA | 9.16% | |
| Givaudan SA | 8.88% | |
| Swiss Re AG | 8.21% | |
| Last data update | 13.01.2026 | |
| TER | 0.28% |
|---|---|
| TER date | 30.06.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.60% |
| Ongoing Charges *** | 0.28% |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |